IBIO Earnings iBio, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q3 2026 | 2026-03-31 | -0.25 | 2026-05-12 | 10-Q |
| Q2 2026 | 2025-12-31 | -0.19 | 2026-02-10 | 10-Q |
| Q1 2026 | 2025-09-30 | -0.11 | 2025-11-12 | 10-Q |
| FY 2025 | 2025-06-30 | -1.75 | 2025-09-05 | 10-K |
| Q3 2026 | 2025-03-31 | -1.44 | 2026-05-12 | 10-Q |
| Q2 2026 | 2024-12-31 | -0.94 | 2026-02-10 | 10-Q |
| Q1 2026 | 2024-09-30 | -0.46 | 2025-11-12 | 10-Q |
| FY 2025 | 2024-06-30 | -6.50 | 2025-09-05 | 10-K |
| Q3 2025 | 2024-03-31 | -7.62 | 2025-05-02 | 10-Q |
| Q2 2025 | 2023-12-31 | -9.15 | 2025-02-10 | 10-Q |
| Q1 2025 | 2023-09-30 | -4.80 | 2024-11-12 | 10-Q |
| FY 2024 | 2023-06-30 | -106.19 | 2024-09-20 | 10-K |
| Q3 2024 | 2023-03-31 | -111.28 | 2024-05-13 | 10-Q |
| Q2 2024 | 2022-12-31 | -110.85 | 2024-02-09 | 10-Q |
| Q1 2024 | 2022-09-30 | -2.05 | 2023-11-14 | 10-Q |
| FY 2023 | 2022-06-30 | -5.78 | 2023-09-27 | 10-K |
| Q3 2023 | 2022-03-31 | -3.82 | 2023-05-15 | 10-Q |
| Q2 2023 | 2021-12-31 | -2.40 | 2023-02-14 | 10-Q |
| Q3 2023 | 2021-09-30 | -3.82 | 2023-05-15 | 10-Q |
| FY 2022 | 2021-06-30 | -3.00 | 2022-10-11 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.